发明名称 |
Liquid oral simvastatin compositions |
摘要 |
A suspension which is suitable for oral administration, comprising simvastatin, at least one suspending agent, and at least one preservative, wherein at least 90 wt % of the particles of simvastatin are less than 100 μm in diameter. The present invention also includes uses of the suspension and methods of making the suspension. |
申请公布号 |
US9597289(B2) |
申请公布日期 |
2017.03.21 |
申请号 |
US200712298451 |
申请日期 |
2007.04.26 |
申请人 |
ROSEMONT PHARMACEUTICALS LTD. |
发明人 |
Driver Phillip |
分类号 |
A61K9/10;A61K31/22;A61K9/00;A61K31/351;A61P3/06;A61K31/366 |
主分类号 |
A61K9/10 |
代理机构 |
Thompson Hine LLP |
代理人 |
Thompson Hine LLP |
主权项 |
1. An aqueous suspension which is suitable for oral administration, wherein 5 ml of suspension comprises:AmountConstituent(mg/5 ml)Purified WaterQ.S.Magnesium Aluminium silicate20Propylene glycol75Methyl hydroxybenzoate8Ethyl hydroxybenzoate2Propyl hydroxybenzoate0.8Carmellose sodium10Simethicone1Citric Acid Monohydrate3.75Disodium Hydrogen Phosphate anhydrous11.25Sodium Lauryl sulphate0.05Simvastatin having d90 ≦ 20 μm20. |
地址 |
Leeds GB |